Del Pharma SNC
Del Pharma reported total assets of 36,943 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).
The score of Del Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +191 % Total assets -16 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Del Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 20 Jun 2025
- Year ended 31 Dec 2023filed on 15 Jun 2024
- Year ended 31 Dec 2022filed on 16 Jun 2023
- Year ended 31 Dec 2021filed on 23 Jul 2022
Del Pharma's financial analysis
- Solvency44.1%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Del Pharma
Del Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0721.527.966
- VAT number
- BE0721527966
- Peppol
- Registered · 0208:0721527966 · as of 10 Nov 2026
- Legal form
- SNC
- Incorporated
- 25 Feb 2019
- Registered office
- 7000 Mons
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Del Pharma (SNC) has been based in Mons since 2019, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 5,967 € and equity of 16,307 €; its revenue is not published. Its solvency stands at 44.1%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Del Pharma
Companies in the same business, of comparable size and area, outside its group.
- Grace Partner Retail sale of pharmaceutical products Quaregnon · balance sheet 19,066 €
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- LEJV Retail sale of pharmaceutical products Bertrix · balance sheet 34,528 €
- Siga Pharm Retail sale of pharmaceutical products Uccle · balance sheet 46,193 €
- Vanfleteren Pieter Retail sale of pharmaceutical products Antwerp · balance sheet 52,894 €
- Helephar Retail sale of pharmaceutical products Wingene · balance sheet 55,332 €
- Itipharma Ghyselen Retail sale of pharmaceutical products Soignies · balance sheet 61,934 €
- Tilosa Retail sale of pharmaceutical products Lokeren · balance sheet 70,195 €
Frequently asked questions about Del Pharma
What is the revenue of Del Pharma?
Del Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Del Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0721527966 for Del Pharma, if the company is VAT-registered. Its company number (CBE) is 0721.527.966.
Where is the registered office of Del Pharma?
According to the CBE register, the registered office of Del Pharma is in 7000 Mons.
What is the equity of Del Pharma?
At the close of the 2025 financial year, the equity of Del Pharma amounts to 16,307 €, a solvency of 44.1% of total assets.
Who manages Del Pharma?
The register lists 1 active mandates at Del Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Del Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →